Measurement of myocardium at risk and salvage in myocardial infarction with ST-segment depression

Patricia Pellikka, T. Behrenbeck, K. C. Huber, Raymond J Gibbons

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

A patient with symptoms of acute myocardial infarction but ST-segment depression rather than elevation constitutes a clinical dilemma for which few guidelines exist. Herein we describe such a patient, in whom serial tomographic imaging with a new radiopharmaceutical agent, technetium-99m sestamibi, was useful in demonstrating a large area of myocardium at risk and subsequent substantial benefit from acute reperfusion therapy. Because this perfusion agent washes out slowly from the myocardium, imaging can be delayed for several hours; thus, acute reperfusion therapy can be performed without delay. Subsequent imaging, however, will reflect myocardial perfusion at the time of administration of the radionuclide. Additional studies with this agent may be valuable in identifying those patients with ST-segment depression who will benefit from acute reperfusion therapy.

Original languageEnglish (US)
Pages (from-to)1222-1226
Number of pages5
JournalMayo Clinic Proceedings
Volume65
Issue number9
StatePublished - 1990

Fingerprint

Reperfusion
Myocardium
Myocardial Infarction
Perfusion
Technetium Tc 99m Sestamibi
Radiopharmaceuticals
Radioisotopes
Therapeutics
Guidelines

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Measurement of myocardium at risk and salvage in myocardial infarction with ST-segment depression. / Pellikka, Patricia; Behrenbeck, T.; Huber, K. C.; Gibbons, Raymond J.

In: Mayo Clinic Proceedings, Vol. 65, No. 9, 1990, p. 1222-1226.

Research output: Contribution to journalArticle

@article{ed3cba430c3849ce8f646cf5bfe921f5,
title = "Measurement of myocardium at risk and salvage in myocardial infarction with ST-segment depression",
abstract = "A patient with symptoms of acute myocardial infarction but ST-segment depression rather than elevation constitutes a clinical dilemma for which few guidelines exist. Herein we describe such a patient, in whom serial tomographic imaging with a new radiopharmaceutical agent, technetium-99m sestamibi, was useful in demonstrating a large area of myocardium at risk and subsequent substantial benefit from acute reperfusion therapy. Because this perfusion agent washes out slowly from the myocardium, imaging can be delayed for several hours; thus, acute reperfusion therapy can be performed without delay. Subsequent imaging, however, will reflect myocardial perfusion at the time of administration of the radionuclide. Additional studies with this agent may be valuable in identifying those patients with ST-segment depression who will benefit from acute reperfusion therapy.",
author = "Patricia Pellikka and T. Behrenbeck and Huber, {K. C.} and Gibbons, {Raymond J}",
year = "1990",
language = "English (US)",
volume = "65",
pages = "1222--1226",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "9",

}

TY - JOUR

T1 - Measurement of myocardium at risk and salvage in myocardial infarction with ST-segment depression

AU - Pellikka, Patricia

AU - Behrenbeck, T.

AU - Huber, K. C.

AU - Gibbons, Raymond J

PY - 1990

Y1 - 1990

N2 - A patient with symptoms of acute myocardial infarction but ST-segment depression rather than elevation constitutes a clinical dilemma for which few guidelines exist. Herein we describe such a patient, in whom serial tomographic imaging with a new radiopharmaceutical agent, technetium-99m sestamibi, was useful in demonstrating a large area of myocardium at risk and subsequent substantial benefit from acute reperfusion therapy. Because this perfusion agent washes out slowly from the myocardium, imaging can be delayed for several hours; thus, acute reperfusion therapy can be performed without delay. Subsequent imaging, however, will reflect myocardial perfusion at the time of administration of the radionuclide. Additional studies with this agent may be valuable in identifying those patients with ST-segment depression who will benefit from acute reperfusion therapy.

AB - A patient with symptoms of acute myocardial infarction but ST-segment depression rather than elevation constitutes a clinical dilemma for which few guidelines exist. Herein we describe such a patient, in whom serial tomographic imaging with a new radiopharmaceutical agent, technetium-99m sestamibi, was useful in demonstrating a large area of myocardium at risk and subsequent substantial benefit from acute reperfusion therapy. Because this perfusion agent washes out slowly from the myocardium, imaging can be delayed for several hours; thus, acute reperfusion therapy can be performed without delay. Subsequent imaging, however, will reflect myocardial perfusion at the time of administration of the radionuclide. Additional studies with this agent may be valuable in identifying those patients with ST-segment depression who will benefit from acute reperfusion therapy.

UR - http://www.scopus.com/inward/record.url?scp=0025009143&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025009143&partnerID=8YFLogxK

M3 - Article

C2 - 2144884

AN - SCOPUS:0025009143

VL - 65

SP - 1222

EP - 1226

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 9

ER -